Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis

被引:37
|
作者
Zhang, Jing [1 ,2 ,3 ]
Liu, Jiaming [1 ,2 ,4 ]
Zhu, Chenjing [1 ,2 ]
He, Jialing [1 ,2 ]
Chen, Jinna [1 ,2 ]
Liang, Yunliu [1 ,2 ]
Yang, Feng [1 ,2 ]
Wu, Xin [1 ,2 ]
Ma, Xuelei [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China
[4] Sichuan Univ, West China Hosp, Lab Reconstruct Urol, Dept Urol,Inst Urol, Chengdu 610041, Peoples R China
关键词
VEGF; cervical cancer; prognosis; FACTOR-C EXPRESSION; VEGF EXPRESSION; CARCINOMA; SURVIVAL; SERUM; RADIOTHERAPY; METASTASIS; PREDICTORS;
D O I
10.18632/oncotarget.15044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic role of vascular endothelial growth factor (VEGF) in cervical cancer is controversial to date. The aim of this study was to evaluate the prognostic value of VEGF and VEGF-C in patients with cervical cancer. Relevant studies were identified by systematic search of the PubMed and Embase database. The primary data of eligible studies was hazard ratio (HR) with 95% confidence interval (95% CI) of survival outcomes, including overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS). Pooled HR (95% CI) was calculated to evaluate the prognostic role of VEGF and VEGF-C in cervical cancer patients. The methodological qualities of the included studies were assessed using REMARK. Fourteen eligible articles including 1306 patients were included in the meta-analysis. The pooled HRs (95% CIs) of VEGF for OS and DFS/PFS were 2.29 [1.27, 4.14] and 2.77 [1.37, 5.62], respectively. The HR (95% CI) of VEGF-C for OS was 3.94 [2.22, 6.99]. This meta-analysis suggested that high expressions of VEGF and VEGF-C were significantly associated with poor survival outcome in cervical cancer patients.
引用
收藏
页码:24797 / 24803
页数:7
相关论文
共 50 条
  • [41] Angiogenesis and colorectal cancer:: a predictive and prognostic role for the vascular endothelial growth factor
    Gil-Bazo, I
    Rodríguez, J
    Páramo, JA
    García-Foncillas, J
    [J]. MEDICINA CLINICA, 2004, 123 (10): : 396 - 397
  • [42] Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer
    Koutras, Angelos
    Kotoula, Vasiliki
    Fountzilas, George
    [J]. PHARMACOGENOMICS, 2015, 16 (01) : 79 - 94
  • [43] Vascular endothelial growth factor A - a systematic review and meta-analysis of expression patterns in breast cancer
    Adams, Arthur
    Vermeulen, Jeroen
    Zuithoff, Peter
    Van der Wall, Elsken
    Lamberts, Laetitia
    de Vries, Elisabeth
    de Jong, Johannes
    Van Dam, Gooitzen
    van Diest, Paul J.
    Mali, Willem P. Th. M.
    Elias, Sjoerd G.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [44] Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis
    Xu, Yipeng
    Zhu, Shaoxing
    [J]. TUMOR BIOLOGY, 2014, 35 (02) : 1307 - 1311
  • [45] Prognostic Role of Epidermal Growth Factor Receptor in Head and Neck Cancer: A Meta-Analysis
    Zhu, Xiaoli
    Zhang, Fengmei
    Zhang, Wei
    He, Jing
    Zhao, Yulan
    Chen, Xingming
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (06) : 387 - 397
  • [46] A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer
    Zhou, Jiupeng
    Yang, Yuanli
    Zhang, Yongfeng
    Liu, Heng
    Dou, Quanli
    [J]. PLOS ONE, 2018, 13 (11):
  • [47] Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis
    Guo, Baoping
    Liu, Yan
    Tan, Xiaohong
    Cen, Hong
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1418 - 1425
  • [48] The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
    Ruan, Guanyu
    Ye, Lixiang
    Liu, Guifen
    An, Jian
    Sehouli, Jalid
    Sun, Pengming
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 521 - 528
  • [49] Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis
    Lee, Y. H.
    Song, G. G.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 14396 - 14405
  • [50] Vascular endothelial growth factor C as a predictive factor in cervical cancer?
    Biedka, Marta
    Makarewicz, Roman
    Lebioda, Andrzej
    Kardymowicz, Hanna
    Goralewska, Alina
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (02): : 87 - 92